News _[+]

Bellevue, WA -- Taplmmune, Inc. (TPIV.OB) announced that it has retained Wolfe Axelrod Weinberger Associates LLC as its investor relations counsel to communicate its strategic goals and business opportunities in order to increase investor awareness and thereby enhance shareholder value.

Denis Corin, President, stated, "Taplmmune has made significant strides recently and we believe that it is now appropriate to take our message of growth and future success to the investment community.  To assist us in communicating with both Wall Street and Main Street, we have selected Wolfe Axelrod Weinberger Associates to assist us in our investor relations activities because of its successful and focused experience working with microcap companies and its extensive network of investment contacts.  We look forward to working closely with Wolfe Axelrod Weinberger to accomplish our primary objective of increasing shareholder value."

_________________________________

About TapImmune Inc.

Taplmmune Inc. is a biotechnology company specializing in the development of innovative cell based immunotherapeutics and vaccines in the areas of oncology and infectious disease.  The Company's lead product candidate, the AdhTAP vaccine enhancer is designed to restore and augment antigen presentation and subsequent recognition and killing of cancer cells by the immune system. The Company is currently planning the development of AdhTAP for the commencement of clinical manufacturing and toxicology studies. The Company is also developing a TAP based prophylactic vaccine which initial tests indicate may increase the efficacy of targeted prophylactic vaccines by up to 1000 times.

As a vaccine, our TAP technology is not only needed but could significantly improve the efficacy of many current prophylactic vaccines and enhance the creation of new ones in the fight against many pandemic infectious diseases. As a cancer therapy, our TAP vaccine alone or in combination with others could prove to be a key component of a more successful assault on cancer.

About Wolfe Axelrod Weinberger Associates LLC

Wolfe Axelrod Weinberger Associates LLC (WAW) has been representing publicly traded emerging growth companies to both Wall Street and Main Street for over 25 years. WAW designs and implements pro-active, creative and aggressive programs that enable our clients to lower their cost of capital and capture the attention they deserve from the investment community and the media.